These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23031192)

  • 41. Does cognitive performance map to categorical diagnoses of schizophrenia, schizoaffective disorder and bipolar disorder? A discriminant functions analysis.
    Van Rheenen TE; Bryce S; Tan EJ; Neill E; Gurvich C; Louise S; Rossell SL
    J Affect Disord; 2016 Mar; 192():109-15. PubMed ID: 26720009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia.
    de la Serna E; Andrés-Perpiñá S; Puig O; Baeza I; Bombin I; Bartrés-Faz D; Arango C; Gonzalez-Pinto A; Parellada M; Mayoral M; Graell M; Otero S; Guardia J; Castro-Fornieles J
    Schizophr Res; 2013 Jan; 143(1):125-31. PubMed ID: 23182439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS).
    Stone WS; Mesholam-Gately RI; Braff DL; Calkins ME; Freedman R; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Light GA; Nuechterlein KH; Olincy A; Radant AD; Siever LJ; Silverman JM; Sprock J; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Turetsky BI; Seidman LJ
    Schizophr Res; 2015 Apr; 163(1-3):32-7. PubMed ID: 25497440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive correlates of verbal memory and verbal fluency in schizophrenia, and differential effects of various clinical symptoms between male and female patients.
    Brébion G; Villalta-Gil V; Autonell J; Cervilla J; Dolz M; Foix A; Haro JM; Usall J; Vilaplana M; Ochoa S
    Schizophr Res; 2013 Jun; 147(1):81-85. PubMed ID: 23578747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia.
    Asevedo E; Rizzo LB; Gadelha A; Mansur RB; Ota VK; Berberian AA; Scarpato BS; Teixeira AL; Bressan RA; Brietzke E
    Physiol Behav; 2014 Apr; 129():194-8. PubMed ID: 24576679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study.
    Impey D; Baddeley A; Nelson R; Labelle A; Knott V
    J Neural Transm (Vienna); 2017 Nov; 124(11):1489-1501. PubMed ID: 28864916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7.
    Hemager N; Plessen KJ; Thorup A; Christiani C; Ellersgaard D; Spang KS; Burton BK; Gregersen M; Søndergaard A; Greve AN; Gantriis DL; Poulsen G; Seidman LJ; Mors O; Nordentoft M; Jepsen JRM
    JAMA Psychiatry; 2018 Aug; 75(8):844-852. PubMed ID: 29926086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia.
    Xavier RM; Pan W; Dungan JR; Keefe RSE; Vorderstrasse A
    Schizophr Res; 2018 Mar; 193():83-90. PubMed ID: 28693755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.
    Şevik AE; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Gürses N; Yıldız M
    Schizophr Res; 2011 Aug; 130(1-3):195-202. PubMed ID: 21592733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Executive functions and cognitive deficits in schizophrenia: comparisons between probands, parents and controls in India.
    Bhatia T; Garg K; Pogue-Geile M; Nimgaonkar VL; Deshpande SN
    J Postgrad Med; 2009; 55(1):3-7. PubMed ID: 19242070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Complex Relationship Among Formal Thought Disorders, Neurocognition, and Functioning in Nonacutely Ill Schizophrenia Patients.
    Comparelli A; Corigliano V; Forcina F; Bargagna P; Montalbani B; Falcone G; Nardella A; Stampatore L; Salzer M; Pompili M
    J Nerv Ment Dis; 2020 Jan; 208(1):48-55. PubMed ID: 31738225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia.
    Fryer SL; Roach BJ; Ford JM; Turner JA; van Erp TG; Voyvodic J; Preda A; Belger A; Bustillo J; O'Leary D; Mueller BA; Lim KO; McEwen SC; Calhoun VD; Diaz M; Glover G; Greve D; Wible CG; Vaidya J; Potkin SG; Mathalon DH
    Neuropsychopharmacology; 2015 Nov; 40(12):2705-14. PubMed ID: 25944410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metamemory in schizophrenia: retrospective confidence ratings interact with neurocognitive deficits.
    Eifler S; Rausch F; Schirmbeck F; Veckenstedt R; Mier D; Esslinger C; Englisch S; Meyer-Lindenberg A; Kirsch P; Zink M
    Psychiatry Res; 2015 Feb; 225(3):596-603. PubMed ID: 25530415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
    Fond G; Berna F; Boyer L; Godin O; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chereau I; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Portalier C; Roux P; Vehier A; Yazbek H; Schürhoff F; Bulzacka E;
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):17-26. PubMed ID: 28349247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?
    Balzan RP; Neaves A; Denson LA; Liu D; Galletly C
    Cogn Neuropsychiatry; 2014; 19(6):471-84. PubMed ID: 24749790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomised controlled trial of adjunctive yoga and adjunctive physical exercise training for cognitive dysfunction in schizophrenia.
    Bhatia T; Mazumdar S; Wood J; He F; Gur RE; Gur RC; Nimgaonkar VL; Deshpande SN
    Acta Neuropsychiatr; 2017 Apr; 29(2):102-114. PubMed ID: 27514629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study.
    Kern RS; Gold JM; Dickinson D; Green MF; Nuechterlein KH; Baade LE; Keefe RS; Mesholam-Gately RI; Seidman LJ; Lee C; Sugar CA; Marder SR
    Schizophr Res; 2011 Mar; 126(1-3):124-31. PubMed ID: 21159492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes and cognitive deficits in chronic schizophrenia: a case-control study.
    Han M; Huang XF; Chen DC; Xiu M; Kosten TR; Zhang XY
    PLoS One; 2013; 8(6):e66299. PubMed ID: 23840437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia.
    Xiu MH; Wang D; Chen S; Du XD; Chen DC; Chen N; Wang YC; Yin G; Zhang Y; Tan YL; Cho RY; Soares JC; Zhang XY
    Psychiatry Res; 2018 May; 263():147-153. PubMed ID: 29554544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.